Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome

Stroke

Volumn 34, Issue 9, 2003, Pages 2208-2214

  Baird, Tracey A ^a   Parsons, Mark W ^a   Phanh, Thanh ^b   Butcher, Ken S ^a   Desmond, Patricia M ^b   Tress, Brian M ^b   Colman, Peter G ^b   Chambers, Brian R ^b   Davis, Stephen M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

Brain ischemia; Glucose; Hyperglycemia; Magnetic resonance imaging, diffusion weighted; Prospective studies

Indexed keywords

GLUCOSE;

AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE EXACERBATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; STROKE; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING;

ACUTE DISEASE; AGED; BLOOD GLUCOSE; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FIBRINOLYTIC AGENTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0041917474     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000085087.41330.FF     Document Type: Article

References (45)

1. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes: the Copenhagen Stroke Study. Stroke. 1994;25:1977-1984.
2. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, Carlin J, Ratnaike S. Stroke topography and outcome in relation to hyperglycemia and diabetes. J Neurol Neurosurg Psychiatry. 1992;55:263-270.
3. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
4. Bruno A, Biller J, Adams HP Jr, Clark WR, Woolson RF, Williams LS, Hansen MD. Acute blood glucose level and outcome from ischemic stroke: Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999;52:280-284.
5. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303-1306.
6. Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, Colman PG, Jerums G, Chambers BR, Davis SM. The influence of diabetes and hyperglycemia on stroke incidence and outcome. J Clin Neurosci. 2002;9:618-626.
7. Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogen EL. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology. 1991;41:899-905.
8. Prado R, Ginsberg MD, Dietrich WD, Watson BD, Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab. 1988;8:186-192.
9. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute Hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-28.
10. Mankovsky BN, Patrick JT, Metzger BE, Saver JL. The size of subcortical ischemic infarction in patients with and without diabetes mellitus. Clin Neurol Neurosurg. 1996;98:137-141.
11. Kushner M, Nencini P, Reivich M, Rango M, Jamieson D, Fazekes F, Zimmerman R, Chawluk J, Alavi A, Alves W. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism and clinical outcome. Ann Neurol. 1990;28:129-135.
12. Toni D, De Michele M, Fiorelli M, Bastianello S, Sacchetti ML, Montinaro E, Zanette EM, Argentino C. Influence of hyperglycemia on infarct size and clinical outcome of ischemic stroke patients with intracranial arterial occlusion. J Neurol Sci. 1994;123:129-133.
13. Matcher DB, Devine GW, Heyman A, Feussner JR. The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med. 1992;117:449-456.
14. Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol. 1990;47:1174-1177.
15. de Courten-Myers G, Myers RE, Schoolfield L. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke. 1988;19:623-630.
16. O'Neill PA, Davies I, Fullerton KJ, Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke. 1991;22:842-847.
17. Christensen H, Boysen G. Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur J Neurol. 2002;9:297-301.
18. Sacks DB, Bruns DE, Goldstein DE, MacLaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48:436-472.
19. Wang Y, Lim LLY, Levi C, Heller RF, Fisher JF. Influence of hyperglycemia on stroke mortality. J Stroke Cerebrovasc Dis. 2001;10:11-18.
20. Mastrototaro J. The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab. 1999;12:751-758.
21. Davidson MB. How do we diagnose diabetes and measure blood glucose control? Diabetes Spectrum. 2001;14:67-71.
22. Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke. 2001;32:1581-1587.
23. Tissue plasminogen activator for acute ischemic stroke: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
24. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusion and perfusion weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002;51:28-37.
25. Schellinger PD, Fiebach JB, Jansen O, Ringleb PA, Mohr A, Steiner T, Heiland S, Schwab S, Pohlers O, Ryssel H, et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol. 2001;49:460-469,
26. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996;27:1817-1820.
27. Tracey F, Crawford VL, Lawson JT, Buchanan KD, Stout RW. Hyperglycemia and mortality from acute stroke. Q J Med. 1993;86:439-446.
28. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WA. Effects of admission hyperglycemia on stroke mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71.
29. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Monting A, Schumacher M, Lucking H. Hyperglycemia in patients with focal cerebral ischaemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis. 2002;13:89-94.
30. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 1982;32:1239-1246.
31. Ginsberg MD, Prado R, Dietrich WD, Busto R, Watson BD. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke. 1987;18:570-574.
32. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg. 1995;82:262-268.
33. Auer RN. Insulin, blood glucose levels, and ischemic brain damage. Neurology. 1998;51:S39-S43.
34. Keir SL, Wardlaw JM. Systematic review of diffusion and perfusion imaging in acute ischemic stroke. Stroke. 2000;31:2723-2731.
35. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers G. Is early ischemic volume on diffusion weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke. 2000;31:2597-2602.
36. Barber PA, Darby DG, Desmond PM. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted magnetic resonance imaging. Neurology. 1998;51:418-426.
37. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging: Citicoline 010 Investigators. Ann Neurol. 2000;48: 713-722.
38. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-799.
39. Moss SE, Klein R, Klein BE, Meuer SM. The association of glycemia and cause specific mortality in a diabetic population. Arch Intern Med. 1994;154:2473-2479.
40. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE, for the NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669-674.
41. Horowitz SH, Zito JL, Donnarumma R, Patel M, Alvir J. Clinical-radiological correlations within the first five hours of cerebral infarction. Acta Neurol Scand. 1992;86:207-214.
42. Toni D, Sacchetti ML, Argentino C, Gentile M, Cavaletti C, Prontoni M, Fieschi C. Does hyperglycaemia play a role on the outcome of acute ischemic stroke patients? J Neurol. 1992;239:382-386.
43. Berger L, Hakim AM. The association of hyperglycemia with cerebral edema in stroke. Stroke. 1986;17:865-871.
44. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
45. Van den Berghe GWP, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.